# 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

> **NCT02347423** · PHASE2 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 824 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Primary series of immunisation comprised by 3 vaccinations IPV-Al SSI
- **BIOLOGICAL:** IPV Vaccine SSI

## Key facts

- **NCT ID:** NCT02347423
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-09
- **Final completion:** 2015-09-26
- **Target enrollment:** 824 (ACTUAL)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02347423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02347423, "3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02347423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*